TNF and cancer: However, in human breast, ovarian and HNSCC cancers, our group and others have demonstrated the functional alteration of TA-pDC in their capacity to secrete IFN-α in response to TLR9 ligand, resulting from TGF-β1 and TNF-α produced in the TME [358,359,360,361].